Anticancer agent 184

• UNSPSC Description:

  Anticancer agent 184 (Compound 6o) is a novel, effective and low toxic anticancer drug. Anticancer agent 184 induces apoptosis by blocking the S phase[1].

• Target Antigen:

  Apoptosis

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/anticancer-agent-184.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N1[C@@H]([C@H]2OC(C3=C2C=CC(OC)=C3OC)=O)C4=C(OC)C(OCO5)=C5C(CC6CN(C(OCC7=CC=CC=C7)=O)C6)=C4CC1)OC(C)(C)C

• Molecular Weight:

  702.75

• References & Citations:

  [1]Li D, et al. Structural Modification of Noscapine via Photoredox/Nickel Dual Catalysis for the Discovery of S-Phase Arresting Agents. ACS Medicinal Chemistry Letters, 2024.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  9007-83-4